Bloomsbury Genetic Therapies
Bloomsbury Genetic Therapies is a clinical-stage biotechnology company focused on developing gene therapy treatments for patients with rare neurological and metabolic diseases. The company utilizes gene therapy technologies and collaborates with University College London and contract development organizations to create therapies.
- Gene therapy treatments
- Innovative therapeutic programs
- Clinical-stage biotechnology solutions
Locations
Digital Popularity
Social Media
Competitors
Viramal is a specialist pharmaceutical company based in the UK and Sweden, focused on developing transformative biological and vaginal well-being products for women.
Ori Biotech is dedicated to revolutionising the manufacturing of cell and gene therapies, making them more accessible to patients in need.
Company Details
Bloomsbury Genetic Therapies is operated by Bloomsbury Genetic Therapies Limited and is a Active company incorporated on 31 August 2021 with the registered office located in Cambridge, Cambridgeshire. Bloomsbury Genetic Therapies Limited was registered 4 years ago.
Status
Active
Size
Micro
Directors
7
Age
4 years old
Employees
6
Turnover
Unreported
Total Assets
£2.94M
Cash in Bank
£2.43M
Total Liabilities
-£1.65M
Teams
5
3
2
Co-Founder And Chief Executive Officer • Joined Apr 2022
Chief Operating Officer And Chief Legal Officer • Joined Sep 2022
Board Director • Joined Apr 2022
Board Director • Joined Aug 2022
SVP, Head Of Regulatory Affairs And Non-Clinical Safety, Toxicology & Biodistribution • Joined May 2022
Co-Founder And Chief Executive Officer • Joined Apr 2022
Board Director • Joined Apr 2022
Board Director • Joined Aug 2022
Chief Operating Officer And Chief Legal Officer • Joined Sep 2022
SVP, Head Of Regulatory Affairs And Non-Clinical Safety, Toxicology & Biodistribution • Joined May 2022